Litigation Details for Lu v. Relypsa, Inc. (N.D. Cal. 2016)
✉ Email this page to a colleague
Lu v. Relypsa, Inc. (N.D. Cal. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-08-12 |
| Court | District Court, N.D. California | Date Terminated | 2016-09-12 |
| Cause | 28:1331 Fed. Question: Securities Violation | Assigned To | William Horsley Orrick III |
| Jury Demand | Plaintiff | Referred To | |
| Parties | KENNETH J. HILLAN | ||
| Patents | 7,556,799; 8,147,873; 8,216,560; 8,282,913; 8,287,847; 8,337,824; 8,475,780; 8,778,324; 8,889,115 | ||
| Attorneys | Hilary Hellmuth Mattis | ||
| Firms | Faruqi & Faruqi LLP; Latham and Watkins | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Lu v. Relypsa, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Lu v. Relypsa, Inc. (N.D. Cal. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-08-12 | 1 | The issued methods of treatment patents (U.S. Patent Nos. 7,556,799, 24 8,216,560, 8,287,847, 8,475,…successfully obtained 9 patents 20 associated with Veltassa. The patents and patent applications relating…Relypsa. The issued composition of matter patents (U.S. Patent Nos. 8,147,873, 8,282,913, 22 and 8,337,824…evergreening its patent portfolio. Relypsa 2 currently has at least two pending patent applications…of its patent portfolio. Indeed, Relypsa appears to be in the process of evergreening its patent 19 portfolio | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
